Blood test triggers early attack on returning bladder cancer
NCT ID NCT04138628
Summary
This study tests if giving immunotherapy earlier improves outcomes for bladder cancer patients. It involves 154 adults who had their bladder removed and now show tiny signs of cancer returning in their blood, even before scans can see it. Researchers use a blood test to detect these early signs and then give the drug atezolizumab, hoping this early treatment leads to better survival than waiting for visible tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aalborg Universitetshospital
Aalborg, 9100, Denmark
-
Aarhus University Hospital
Aarhus, 8200, Denmark
-
Herlev Hospital
Herlev, 2730, Denmark
-
Odense Universitetshospital
Odense, 5000, Denmark
-
Rigshospitalet
Copenhagen, 2100, Denmark
Conditions
Explore the condition pages connected to this study.